| Issue Date | Title | Author(s) | Type | scopus | WOS | Fulltext/Archive link |
| 2011 | Activation of Checkpoint Kinase 2 (Chk2) Contributes to the Antitumour Synergy between Igf1 Receptor Kinase Inhibitor Nvp-Aew541 and Sunitinib in Hepatocellular Carcinoma | OU, DA-LIANG; SHEN, YING-CHUN; HSU, CHIUN; CHENG, ANN-LII | | | | |
| 2011 | Activation of Phosphatidylinositol 3-Kinase/Akt Signaling Pathway Mediates Acquired Resistance to Sorafenib in Hepatocellular Carcinoma Cells | Chen, KF; Chen, HL; Tai, WT; Feng, WC; Hsu, CH; Chen, PJ; Cheng, AL | | | | |
| 2011 | Activation of phosphatidylinositol 3-kinase/Akt signaling pathway mediates acquired resistance to sorafenib in hepatocellular carcinoma cells | PEI-JER CHEN ; CHIH-HUNG HSU ; Kuen-Feng Chen ; ANN-LII CHENG | journal article | 170 | 161 | |
| 2004 | Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers | KENG-HSUEH LAN | journal article | 260 | 240 | |
| 2008 | Adenoid cystic carcinoma of the breast arising in a lipoma mimicking hamartoma: Imaging manifestations and review of the literature | Sung-Hsin Kuo | journal article | | | |
| 2015 | Afatinib (A) versus chemotherapy (CT) for EGFR mutation-positive NSCLC patients (pts) aged >= 65 years: Subgroup analyses of LUX-Lung 3 (LL3) and LUX-Lung 6 (LL6) | Wu, Y. -L.; Sequist, L. V.; Geater, S. L.; Orlov, S.; Lee, K. H.; Tsai, C. -M.; Kato, T.; Kiura, K.; Barrios, C. H.; Schuler, M.; Hirsh, V.; Yamamoto, N.; O'Byrne, K.; Mok, T.; Massey, D.; Maerten, A.; Yang, J. C. -H. | | | | |
| 2016 | Afatinib beyond progression in patients with non-small-cell lung cancer following chemotherapy, erlotinib/gefitinib and afatinib: phase III randomized LUX-Lung 5 trial | Schuler, M.; Yang, J. C. -H.; Park, K.; Kim, J. -H.; Bennouna, J.; Chen, Y. -M.; Chouaid, C.; De Marinis, F.; Feng, J. -F.; Grossi, F.; Kim, D. -W.; Liu, X.; Lu, S. ; Strausz, J.; Vinnyk, Y.; Wiewrodt, R.; Zhou, C.; Wang, B.; Chand, V. K.; Planchard, D. | | 75 | 75 | |
| 2013 | Amiodarone inhibits the entry and assembly steps of hepatitis C virus life cycle | KENG-HSUEH LAN | journal article | 10 | 9 | |
| 2016 | Anaplastic Lymphoma Kinase (ALK) Kinase Domain Mutation Following ALK Inhibitor(s) Failure in Advanced ALK Positive Non–Small-Cell Lung Cancer: Analysis and Literature Review | Yen-Ting Lin; CHONG-JEN YU ; James Chih-Hsin Yang; JIN-YUAN SHIH | journal article | 13 | 11 | |
| 2016 | Anti-CD40 antibody and toll-like receptor 3 ligand restore dendritic cell-mediated anti-tumor immunity suppressed by morphine | Chang, Ming-Cheng; Chen, Yu-Li; Chen, Yu-Li; Chiang, Ying-Cheng; Chiang, Ying-Cheng; Cheng, Ya-Jung; Cheng, Ya-Jung; Jen, Yu-Wei; Jen, Yu-Wei; Chen, Chi-An; Chen, Chi-An; Cheng, Wen-Fang; Cheng, Wen-Fang; Sun, Wei-Zen; Sun, Wei-Zen | | | | |
| 2006 | The application of Aquaplast Thermoplastic as a bolus material in the radiotherapy of a patient with classic Kaposi’s sarcoma at the lower extremity | Huang, KM; Hsu, CH; Jeng, SC; Ting, LL; Cheng, JC; Huang, WT | | | | |
| 2007 | Arsenic trioxide in patients with hepatocellular carcinoma: A phase II trial | CHIH-HUNG HSU ; ANN-LII CHENG | journal article | 79 | 77 | |
| 2005 | Arsenic trioxide prevents radiation-enhanced tumor invasiveness and inhibits matrix metalloproteinase-9 through downregulation of nuclear factor kappaB. | Wei, LH; Wei, LH; Lai, KP; Chen, CA; Cheng, CH; Cheng, CH; Huang, YJ; Chou, CH; Chou, CH; Kuo, ML; Kuo, ML; Hsieh, CY; Hsieh, CY | | | | |
| 2013 | Association of diabetes mellitus with increased mortality in patients receiving curative surgery for colon cancer | Yu-Yun Shao | journal article | | | |
| 2015 | Association of Environmental Arsenic Exposure, Genetic Polymorphisms of Susceptible Genes, and Skin Cancers in Taiwan | Hsu, Ling-I; Wu, Meei-Maan; Wang, Yuan-Hung; Lee, Cheng-Yeh; Yang, Tse-Yen; Hsiao, Bo-Yu; Chen, Chien-Jen | | 18 | 17 | |
| 2015 | Associations between medical conditions and breast cancer risk in asians: A nationwide population-based study in Taiwan | CHING-HUNG LIN | journal article | 13 | 13 | |
| 2015 | AUY922 effectively targets against activated B cell subtype of diffuse large B-cell lymphoma and low-grade lymphoma cells harboring genetic alteration-associated nuclear factor-κB activation | Sung-Hsin Kuo ; ANN-LII CHENG | journal article | 4 | 0 | |
| 2012 | AUY922, a heat shock protein 90 inhibitor, plus 5-fluorouracil inhibits tumors synergistically in gastric cancer MKN45 xenograft via down regulation of multiple pivotal growth factor receptors and oncoproteins | Yeh, Kun-Huei; Kao, Chiu-Hua; Fan, Hsun-Fang; Cheng, Chih-Jen; Lin, Yu-Lin; Cheng, Ann-Lii; 鄭安理 | | 0 | 0 | |
| 2011 | Axillary vs sentinel lymph node dissectionfor invasive breast cancer [2] | CHING-HUNG LIN | journal article | 8 | 4 | |
| 2015 | AZD3759, an EGFR inhibitor with blood brain barrier (BBB) penetration for the treatment of non-small cell lung cancer (NSCLC) with brain metastasis (BM): Preclinical evidence and clinical cases. | Kim, Dong-Wan ; Yang, James Chih-Hsin ; Chen, Kan ; Cheng, Ziqiang ; Yin, Lucy ; Martin, Paul David ; Yang, Zhenfan ; Jiang, Haiyi ; Ahn, Myung-Ju | | | | |
